InSilico Medicine Cayman TopCo (O15)
XDUS
Closed
Aug 25, 2026
Day's Range
4.8852 wk Range
3.52Overview - O15 - InSilico Medicine Cayman TopCo
Key Statistics
Valuation
Enterprise Value
-387.37M
P/E (Trailing)
‪-1.12‬
EV / EBITDA
‪1.11‬
Profitability
Profit Margin
‪81.52%‬
Operating Margin
‪-625.98%‬
Return on Assets
‪-71.90%‬
Return on Equity
‪-77.94%‬
Ownership
Shares Outstanding
557.41M
Price stats
50-Day Avg
‪4.64‬
200-Day Avg
‪5.77‬
Peers - O15 - InSilico Medicine Cayman TopCo
Peer Comparison
Compared with companies in Software - Infrastructure listed on XDUS.
- O15XDUSInSilico Medicine Cayman TopCo-46.23%52-week change-1.04P/E (Trailing)‪81.52%‬Profit Margin
- 0SUXDUSDigitalOcean Holdings Inc.+72.60%52-week change33.83P/E (Trailing)‪59.85%‬Profit Margin
- 5XBXDUSBandwidth Inc.+68.91%52-week change-92.09P/E (Trailing)‪39.14%‬Profit Margin
- 34Q0XDUSQuantum eMotion Corp.+62.36%52-week change-31.69P/E (Trailing)—Profit Margin
- 92JXDUSMegaport Limited+61.14%52-week change-48.17P/E (Trailing)—Profit Margin
- MKTXDUSMKS Instruments Inc.+60.89%52-week change52.73P/E (Trailing)‪46.73%‬Profit Margin
- VHCXDUSViohalco S.A.+60.81%52-week change—P/E (Trailing)—Profit Margin
Profile Summary - O15 - InSilico Medicine Cayman TopCo
About
InSilico Medicine Cayman TopCo is an artificial intelligence-based biotechnology company focused on drug discovery and development. It leverages generative AI through its Pharma.AI platform, an end-to-end software and automation solution that enhances pharmaceutical research productivity by identifying novel drug…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
